Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000899243-19-008569

Director acquired 20,576 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hayden Michael R · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-03-19 Exercise or conversion : show line 1 in the form +20,576 $3.38 $69,547 50,924 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-19 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −20,576 0 I
Loading xslF345X03/doc4.xml…